This classification describes three genetic criteria for the diagnosis of GBM, IDH-wildtype: telomerase reverse transcriptase (TERT) promoter mutation, epidermal growth factor receptor (EGFR) amplification, and the combined gain of the entire chromosome 7 and loss of entire chromosome 10 [21]. This evidence concerns the gene EGFR and glioblastoma.